CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 38 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,501,716 | $18,231,000 | 10.62% |
| venBio Partners LLC | 3,673,374 | $44,595,000 | 4.24% |
| Sofinnova Investments, Inc. | 3,606,707 | $43,785,000 | 2.63% |
| Omega Fund Management, LLC | 1,335,050 | $16,208,000 | 1.53% |
| Novo Holdings A/S | 2,170,100 | $26,345,000 | 1.09% |
| CLOUGH CAPITAL PARTNERS L P | 1,352,313 | $16,417,000 | 0.73% |
| SECTORAL ASSET MANAGEMENT INC | 541,766 | $6,577,000 | 0.50% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 71,515 | $868,000 | 0.02% |
| CAMBRIDGE TRUST CO | 24,609 | $299,000 | 0.01% |
| Ensign Peak Advisors, Inc | 119,915 | $1,455,000 | 0.00% |